Prevention And Treatment Of Vascular Disease With Recombinant Adeno-Associated Virus Vectors Encoding Apolipoprotein A-I And Apolipoprotein A-I Milano
    4.
    发明申请
    Prevention And Treatment Of Vascular Disease With Recombinant Adeno-Associated Virus Vectors Encoding Apolipoprotein A-I And Apolipoprotein A-I Milano 有权
    用编码载脂蛋白A-I和载脂蛋白A-I的重组腺相关病毒载体预防和治疗血管疾病

    公开(公告)号:US20070202081A1

    公开(公告)日:2007-08-30

    申请号:US10599692

    申请日:2005-04-05

    IPC分类号: A61K48/00 C12N15/00

    摘要: Described herein is a gene therapeutic approach to the prevention and treatment of vascular disease and coronary heart disease; in particular, atherosclerosis. The inventive methods may be used in the prevention and treatment of atherosclerosis, as well as any disease or physiological condition in which atherosclerosis plays a role. The inventive methods involve the gene delivery of ApoA-I or ApoA-IMilano. This may be accomplished by the use of rAAV technology. rAAV virions may be delivered to a mammalian subject by various methodologies, including transplantation of transduced bone marrow cells, direct intramuscular injection, intravenous or portal vein injection or stent delivery.

    摘要翻译: 本文描述了预防和治疗血管疾病和冠心病的基因治疗方法; 特别是动脉粥样硬化。 本发明的方法可用于预防和治疗动脉粥样硬化,以及动脉粥样硬化起作用的任何疾病或生理状况。 本发明的方法涉及ApoA-I或ApoA-IMilano的基因递送。 这可以通过使用rAAV技术来实现。 rAAV病毒粒子可以通过各种方法递送到哺乳动物受试者,包括转移的骨髓细胞的移植,直接肌内注射,静脉内或门静脉注射或支架递送。